HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study of the density of ganglion cells in the terminal bowel of rats with anorectal malformations.

AbstractPURPOSE:
To study the ganglion cells (GC) in the terminal bowel of rats with ethylenethiourea (ETU) induced anorectal malformations (ARM).
METHODS:
The animals were divided into three groups: Group A--normal fetuses from pregnant rats that were not administered ETU; Group B--fetuses without ARM born from pregnant rats that were administered ETU and Group C--fetuses with ARM born from pregnant rats that received ETU. ETU was administered on the 11th day of pregnancy at the dose of 125 mg/kg body weight by gastric gavage. The rats had cesarean section on the 21st day of gestation. The fetuses terminal bowel tissue was analyzed by immunohistochemistry to demonstrate ganglion cells.
RESULTS:
Statistically significant differences were found between groups A, B and C regarding ganglion cell densities. Group A had the highest cell density, followed by Group B and the lowest density was found in Group C.
CONCLUSION:
Ganglion cell densities are decreased in the terminal bowel of rats with ARM.
AuthorsMaurício Macedo, José Luiz Martins, Karine Furtado Meyer, Iberê Cauduro Soares
JournalActa cirurgica brasileira (Acta Cir Bras) 2007 Nov-Dec Vol. 22 Issue 6 Pg. 441-5 ISSN: 0102-8650 [Print] Brazil
PMID18235931 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • S100 Proteins
  • Ethylenethiourea
Topics
  • Anal Canal (abnormalities, innervation, pathology)
  • Animals
  • Cell Count
  • Disease Models, Animal
  • Enteric Nervous System (drug effects, pathology)
  • Ethylenethiourea
  • Female
  • Ganglia (cytology)
  • Immunohistochemistry
  • Pregnancy
  • Rats
  • Rats, Wistar
  • Rectum (abnormalities, innervation, pathology)
  • S100 Proteins (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: